Direct Oral Challenge is a Safe and Effective Strategy to Delabel Low-Risk Penicillin Allergy in Immunocompromised Patients Admitted to the ICU
The Journal of Allergy and Clinical Immunology(2022)
摘要
Increasing evidence supports that adults with low-risk penicillin allergy labels (PALs) can be delabeled with direct oral amoxicillin challenge. Immunocompromised patients admitted acutely are at increased risk of infection and likely benefit disproportionately from delabeling. We investigated the efficacy, safety, effectiveness, and infection outcomes of immunodeficient patients with low-risk PALs delabeled in the intensive care setting.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要